Literature DB >> 8711652

Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients.

D Lieberman1, F Schlaeffer, I Boldur, D Lieberman1, S Horowitz, M G Friedman, M Leiononen, O Horovitz, E Manor, A Porath.   

Abstract

BACKGROUND: The purpose of this study was to assess the causes of community-acquired pneumonia in adult patients admitted to hospital.
METHODS: A prospective study was performed on 346 consecutive adult patients (54% men) of mean (SD) 49.3 (19.5) years (range 17-94) admitted to a university affiliated regional hospital in southern Israel with community-acquired pneumonia over a period of one year. Convalescent serum samples were obtained from 308 patients (89%). The aetiological diagnosis for community-acquired pneumonia was based on positive blood cultures and/or significant changes in antibody titres to Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, respiratory viruses, Coxiella burnetii, Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella sp.
RESULTS: The aetiology of community-acquired pneumonia was identified in 279 patients (80.6%). The distribution of causal agents was as follows: S pneumoniae, 148 patients (42.8%); M pneumoniae, 101 (29.2%); C pneumoniae, 62 (17.9%); Legionella sp, 56 (16.2%); respiratory viruses, 35 (10.1%); C burnetii, 20 (5.8%); H influenzae 19 (5.5%); and other causes, 21 patients (6.0%). In patients above the age of 55 years C pneumoniae was the second most frequent aetiological agent (25.5%). In 133 patients (38.4%) more than one causal agent was found.
CONCLUSIONS: The causal agents for community-acquired pneumonia in Israel are different from those described in other parts of the world. In many of the patients more than one causal agent was found. In all these patients treatment should include a macrolide antibiotic, at least in the first stage of their illness.

Entities:  

Mesh:

Year:  1996        PMID: 8711652      PMCID: PMC473032          DOI: 10.1136/thx.51.2.179

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  24 in total

1.  Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization.

Authors:  A Ortqvist; J Hedlund; L Grillner; E Jalonen; I Kallings; M Leinonen; M Kalin
Journal:  Eur Respir J       Date:  1990-11       Impact factor: 16.671

2.  Interrelationships of viral, mycoplasmal, and bacterial agents in uncomplicated pneumonia.

Authors:  M L Lepow; N Balassanian; J Emmerich; R B Roberts; M S Rosenthal; E Wolinsky
Journal:  Am Rev Respir Dis       Date:  1968-04

3.  Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells.

Authors:  Y Shemer-Avni; D Lieberman
Journal:  J Infect Dis       Date:  1995-05       Impact factor: 5.226

4.  Causes of pneumonia presenting to a district general hospital.

Authors:  R J White; A D Blainey; K J Harrison; S K Clarke
Journal:  Thorax       Date:  1981-08       Impact factor: 9.139

5.  Etiology of community-acquired pneumonia in patients requiring hospitalization.

Authors:  E Berntsson; J Blomberg; T Lagergård; B Trollfors
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

6.  The aetiology of pneumonia. Application of bacterial serology and basic laboratory methods.

Authors:  Y Kerttula; M Leinonen; M Koskela; P H Mäkelä
Journal:  J Infect       Date:  1987-01       Impact factor: 6.072

7.  Etiological diagnosis of pneumonia in military conscripts by combined use of bacterial culture and serological methods.

Authors:  K Lehtomäki; M Leinonen; A Takala; T Hovi; E Herva; M Koskela
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

8.  Prospective study of the aetiology and outcome of pneumonia in the community.

Authors:  M A Woodhead; J T Macfarlane; J S McCracken; D H Rose; R G Finch
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

9.  Microparticle agglutination versus antibody-capture enzyme immunoassay for diagnosis of community-acquired Mycoplasma pneumoniae pneumonia.

Authors:  D Lieberman; D Lieberman; S Horowitz; O Horovitz; F Schlaeffer; A Porath
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-07       Impact factor: 3.267

10.  Use of serology to diagnose pneumonia caused by nonencapsulated Haemophilus influenzae and Moraxella catarrhalis.

Authors:  L A Burman; M Leinonen; B Trollfors
Journal:  J Infect Dis       Date:  1994-07       Impact factor: 5.226

View more
  62 in total

1.  Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice.

Authors:  E Azoulay-Dupuis; V Rieux; M Muffat-Joly; J P Bédos; E Vallée; C Rivier; R Isturiz; C Carbon; P Moine
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

3.  Community-Acquired Pneumonia: An Overview.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

4.  Community epidemiology of Chlamydia and Mycoplasma pneumoniae in LRTI in France over 29 months.

Authors:  Jacques Gaillat; Antoine Flahault; Bertille deBarbeyrac; Jeanne Orfila; Henri Portier; Jean-Pierre Ducroix; Christiane Bébéar; Charles Mayaud
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

5.  Cost-effectiveness of Xpert® MTB/RIF for diagnosing pulmonary tuberculosis in the United States.

Authors:  H W Choi; K Miele; D Dowdy; M Shah
Journal:  Int J Tuberc Lung Dis       Date:  2013-10       Impact factor: 2.373

6.  Efficacy of cethromycin, a new ketolide, against Streptococcus pneumoniae susceptible or resistant to erythromycin in a murine pneumonia model.

Authors:  E Azoulay-Dupuis; J Mohler; J P Bédos; C Barau; B Fantin
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 7.  Optimal therapy for severe pneumococcal community-acquired pneumonia.

Authors:  Manel Luján; Miguel Gallego; Jordi Rello
Journal:  Intensive Care Med       Date:  2006-05-10       Impact factor: 17.440

8.  Development of conventional and real-time nucleic acid sequence-based amplification assays for detection of Chlamydophila pneumoniae in respiratory specimens.

Authors:  K Loens; T Beck; H Goossens; D Ursi; M Overdijk; P Sillekens; M Ieven
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

9.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

10.  Usefulness of PCR and antigen latex agglutination test with samples obtained by transthoracic needle aspiration for diagnosis of pneumococcal pneumonia.

Authors:  A García; B Rosón; J L Pérez; R Verdaguer; J Dorca; J Carratalà; A Casanova; F Manresa; F Gudiol
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.